Open AccessPharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer
Author(s) -
Haitang Yang,
Beibei Sun,
Ke Xu,
Yunfei He,
Tuo Zhang,
Sean R. R. Hall,
Swee T. Tan,
Ralph A. Schmid,
RenWang Peng,
Guohong Hu,
Feng Yao
Publication year - 2021
Publication title -
ebiomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.596
H-Index - 63
ISSN - 2352-3964
DOI - 10.1016/j.ebiom.2021.103457
Subject(s) - transcriptome , dasatinib , biology , interactor , computational biology , cancer , cancer research , lung cancer , bioinformatics , genetics , gene , medicine , microbiology and biotechnology , gene expression , signal transduction , pathology , tyrosine kinase
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom